ADC Therapeutics ADCT
NYSE ADCT
$1.00 +0.04 (+3.80%)
At close: Aug 21, 2026 · 4:00 PM EDT

ADC Therapeutics (ADCT) Selling, General & Administrative (2020 - 2026)

ADC Therapeutics (ADCT) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 ADC Therapeutics 154.55 Mn -64.56 Mn 17.14 Mn 9.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.70 Mn
Mar 31, 2026 9.90 Mn
Sep 30, 2025 8.33 Mn
Jun 30, 2025 8.82 Mn
Mar 31, 2025 9.96 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 10.24 Mn
Mar 31, 2024 12.03 Mn
Sep 30, 2023 9.62 Mn
Jun 30, 2023 12.00 Mn
Mar 31, 2023 15.14 Mn
Sep 30, 2022 19.62 Mn
Jun 30, 2022 18.24 Mn
Mar 31, 2022 19.01 Mn
Sep 30, 2021 16.59 Mn
Jun 30, 2021 19.37 Mn
Mar 31, 2021 17.58 Mn
Sep 30, 2020 14.16 Mn
Jun 30, 2020 15.00 Mn
Mar 31, 2020 5.88 Mn